Past Earnings Performance
Past criteria checks 6/6
United Laboratories International Holdings has been growing earnings at an average annual rate of 29.8%, while the Pharmaceuticals industry saw earnings growing at 5.9% annually. Revenues have been growing at an average rate of 12% per year. United Laboratories International Holdings's return on equity is 21.2%, and it has net margins of 19.7%.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Industry Growth | n/a |
Revenue growth rate | n/a |
Return on equity | n/a |
Net Margin | n/a |
Earnings Update | n/a |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|
Quality Earnings: 3933 has high quality earnings.
Growing Profit Margin: 3933's current net profit margins (19.7%) are higher than last year (13.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 3933's earnings have grown significantly by 29.8% per year over the past 5 years.
Accelerating Growth: 3933's earnings growth over the past year (70.9%) exceeds its 5-year average (29.8% per year).
Earnings vs Industry: 3933 earnings growth over the past year (70.9%) exceeded the Pharmaceuticals industry 1.3%.
Return on Equity
High ROE: 3933's Return on Equity (21.2%) is considered high.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y